Lugo-Fabres, P.H.; Otero-Sastre, L.M.; Bernáldez-Sarabia, J.; Camacho-Villegas, T.A.; Sánchez-Campos, N.; Serrano-Bello, J.; Medina, L.A.; Muñiz-Hernández, S.; de la Cruz, L.; Arenas, I.;
et al. Potential Therapeutic Applications of Synthetic Conotoxin s-cal14.2b, Derived from Californiconus californicus, for Treating Type 2 Diabetes. Biomedicines 2021, 9, 936.
https://doi.org/10.3390/biomedicines9080936
AMA Style
Lugo-Fabres PH, Otero-Sastre LM, Bernáldez-Sarabia J, Camacho-Villegas TA, Sánchez-Campos N, Serrano-Bello J, Medina LA, Muñiz-Hernández S, de la Cruz L, Arenas I,
et al. Potential Therapeutic Applications of Synthetic Conotoxin s-cal14.2b, Derived from Californiconus californicus, for Treating Type 2 Diabetes. Biomedicines. 2021; 9(8):936.
https://doi.org/10.3390/biomedicines9080936
Chicago/Turabian Style
Lugo-Fabres, Pavel H., Leslie M. Otero-Sastre, Johanna Bernáldez-Sarabia, Tanya A. Camacho-Villegas, Noemi Sánchez-Campos, Janeth Serrano-Bello, Luis A. Medina, Saé Muñiz-Hernández, Lizbeth de la Cruz, Isabel Arenas,
and et al. 2021. "Potential Therapeutic Applications of Synthetic Conotoxin s-cal14.2b, Derived from Californiconus californicus, for Treating Type 2 Diabetes" Biomedicines 9, no. 8: 936.
https://doi.org/10.3390/biomedicines9080936
APA Style
Lugo-Fabres, P. H., Otero-Sastre, L. M., Bernáldez-Sarabia, J., Camacho-Villegas, T. A., Sánchez-Campos, N., Serrano-Bello, J., Medina, L. A., Muñiz-Hernández, S., de la Cruz, L., Arenas, I., Barajas-MartÃnez, A., Garcia, D. E., Nuñez-Garcia, L., González-Canudas, J., & Licea-Navarro, A. F.
(2021). Potential Therapeutic Applications of Synthetic Conotoxin s-cal14.2b, Derived from Californiconus californicus, for Treating Type 2 Diabetes. Biomedicines, 9(8), 936.
https://doi.org/10.3390/biomedicines9080936
